January 30 - February 3, 2027
San Diego, CA, USA
January 30 - February 3, 2027
San Diego, CA, USA
The SLAS 2027 International Conference and Exhibition is where the year in life sciences begins—with the people, technologies and ideas already shaping what’s next. Experience breakthrough science, hands-on innovation and high-impact connections that turn early insights into real momentum. Start your year where discovery and technology accelerate—and leave with the energy, partnerships and inspiration to move faster than the field.
Call for Short Course Proposals
Call for Podium and Poster Abstracts + Travel and Innovation Awards: Submission period opens May 4!
Use the form below to join our mailing list to stay on top of SLAS2027 activities, deadlines and registration alerts!

Co-Founder and CEO
Partillion Bioscience
Joe de Rutte, PhD, is the co-founder and CEO of Partillion Bioscience, where he leads the development of innovative tools that advance single-cell analysis and next-generation therapeutics. A recipient of the 2020 SLAS Innovation Award for the Nanovial platform, de Rutte helped transform the technology from an academic breakthrough into commercial tools now supporting more than 100 research programs worldwide. He is an inventor on 12 filed patents, co-author of 21 peer-reviewed publications and remains an active member of the SLAS community through award judging and conference program leadership.

Director, Microtechnologies Laboratory for Pediatric Oncology
Rice University
Julea Vlassakis, PhD, directs the Microtechnologies Laboratory for Pediatric Oncology at Rice University (Houston, TX, USA), where she leads the advancement of targeted and precision therapies for pediatric cancers, with a focus on Ewing sarcoma. She earned her PhD in bioengineering as a National Science Foundation Graduate Fellow and postdoc in the Herr Lab at the University of California, Berkeley where she was the second recipient of the SLAS Graduate Education Fellowship Award. Her research has garnered several honors, including the NIH Director’s New Innovator Award, Burroughs Wellcome Fund Career Award at the Scientific Interface, and the CPRIT Scholar Award from the Cancer Prevention & Research Institute of Texas.